|Articles|May 1, 2016
- Pharmaceutical Executive-05-01-2016
- Volume 36
- Issue 5
Pharmaceutical Executive, May 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive May 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Steering the Change: GSK's Jack Baileyover 9 years ago
Pharma’s Big Push for Valueover 9 years ago
Pharm Exec at the Vantage Pointover 9 years ago
Pharma Under Pressure to Curb Opioid Abuseover 9 years ago
Country Report: Franceover 9 years ago
Pharma Under Fire for Driving "Opioid Abuse Epidemic"Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Targeting CCR5 Receptors
2
Merck to Acquire Cidara for $9.2 Billion
3
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML
4
DEI Changes in Pharma: A Look Back at 2025 & Predictions for 2026
5
